IL97726A - Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds - Google Patents

Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds

Info

Publication number
IL97726A
IL97726A IL9772691A IL9772691A IL97726A IL 97726 A IL97726 A IL 97726A IL 9772691 A IL9772691 A IL 9772691A IL 9772691 A IL9772691 A IL 9772691A IL 97726 A IL97726 A IL 97726A
Authority
IL
Israel
Prior art keywords
compounds
alkyl
oxazoline
pharmaceutical composition
composition according
Prior art date
Application number
IL9772691A
Other languages
English (en)
Inventor
Abraham Fisher
Yoffi Segall
Ezra Shirin
Yishai Karton
Haim Meshulam
Original Assignee
Israel Inst Biolog Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/507,228 external-priority patent/US5053412A/en
Application filed by Israel Inst Biolog Res filed Critical Israel Inst Biolog Res
Publication of IL97726A publication Critical patent/IL97726A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9772691A 1990-04-10 1991-03-28 Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds IL97726A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50770890A 1990-04-10 1990-04-10
US07/507,228 US5053412A (en) 1990-04-10 1990-04-10 Spiro nitrogen-bridged heterocyclic compounds
AU81241/91A AU636047B2 (en) 1990-04-10 1991-07-23 Spiro bridged and unbridged heterocyclic compounds

Publications (1)

Publication Number Publication Date
IL97726A true IL97726A (en) 1994-12-29

Family

ID=27156423

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9772691A IL97726A (en) 1990-04-10 1991-03-28 Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds

Country Status (8)

Country Link
EP (1) EP0452101B1 (fr)
JP (1) JP3266624B2 (fr)
AT (1) ATE181920T1 (fr)
AU (1) AU636047B2 (fr)
CA (1) CA2039826C (fr)
DE (1) DE69131409T2 (fr)
ES (1) ES2137926T3 (fr)
IL (1) IL97726A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
JP3708962B2 (ja) * 1994-08-24 2005-10-19 アストラゼネカ・アクチエボラーグ 治療に有用なスピロ−アザ二環式化合物
US8309577B2 (en) 2008-04-23 2012-11-13 Bristol-Myers Squibb Company Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
US7863291B2 (en) * 2008-04-23 2011-01-04 Bristol-Myers Squibb Company Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
KR20150116466A (ko) * 2009-01-26 2015-10-15 이스라엘 인스티튜트 포 바이올로지컬 리서치 이환형 헤테로사이클릭 스피로 화합물
US9034891B2 (en) 2009-01-26 2015-05-19 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
US8507516B2 (en) 2009-10-28 2013-08-13 Bristol-Myers Squibb Company Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
US8278320B2 (en) 2009-10-28 2012-10-02 Bristol-Myers Squibb Company Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
MX2012004560A (es) * 2009-10-29 2012-05-08 Bristol Myers Squibb Co Compuestos de quinuclidina como ligandos del receptor de acetilcolina nicotinico alfa-7.
CN101798311A (zh) * 2010-04-07 2010-08-11 天津炜杰凯华科技有限公司 顺式西维美林的制备方法
WO2011137313A1 (fr) 2010-04-30 2011-11-03 Bristol-Myers Squibb Company Composés n-oxyde d'amine aza-bicylique en tant que promédicaments de ligands de récepteurs nicotiniques d'acétylcholine alpha-7
WO2013177024A1 (fr) * 2012-05-24 2013-11-28 Bristol-Myers Squibb Company Composés de quinuclidine, 1-azabicyclo[2.2.1]heptane, 1-azabicyclo [3.2.1]octane, et 1-azabicyclo[3.2.2]nonane utiles comme ligands du récepteur alpha-7 nicotinique de l'acétylcholine
JP5714745B2 (ja) * 2014-04-28 2015-05-07 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ α７ニコチン性アセチルコリン受容体リガンドとしてのキヌクリジン化合物
WO2021228123A1 (fr) * 2020-05-12 2021-11-18 北京广为医药科技有限公司 Composé permettant d'ajuster l'activité du récepteur nmda, composition pharmaceutique et utilisation associées

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629276A (en) * 1969-07-16 1971-12-21 Abbott Lab 2-amino-5-spiro-substituted-oxazo compounds
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
GB8816299D0 (en) * 1988-07-08 1988-08-10 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
CA2039826A1 (fr) 1991-10-11
AU8124191A (en) 1993-01-28
AU636047B2 (en) 1993-04-08
EP0452101A3 (en) 1993-02-24
EP0452101A2 (fr) 1991-10-16
JPH06293761A (ja) 1994-10-21
ES2137926T3 (es) 2000-01-01
ATE181920T1 (de) 1999-07-15
DE69131409D1 (de) 1999-08-12
JP3266624B2 (ja) 2002-03-18
DE69131409T2 (de) 2000-02-03
CA2039826C (fr) 2002-01-15
EP0452101B1 (fr) 1999-07-07

Similar Documents

Publication Publication Date Title
US5852029A (en) Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5534520A (en) Spiro compounds containing five-membered rings
DE60113865T2 (de) Piperazin derivate
AU775426B2 (en) New compounds
JP3042894B2 (ja) サブスタンスｐアンタゴニストとしての置換ベンゾラクタム化合物
AU744259B2 (en) Analogs of cocaine
EP0452101B1 (fr) Composés spiro hétérocycliques pontés et non pontés
PL172069B1 (pl) Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL
DK175064B1 (da) Spiro-oxathiolan/quinuclidinforbindelser, præparat indeholdende disse og anvendelse af disse til fremstilling af et farmaceutisk præparat
US5407938A (en) Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
NO177711B (no) Analogifremgangsmåte for fremstilling av terapautisk aktive azabicyklo- og azacyklo- oksimer og -aminer
US5053412A (en) Spiro nitrogen-bridged heterocyclic compounds
FI106797B (fi) Menetelmä atsabisyklo [2.2.1] heptan-3-onioksiimien valmistamiseksi
EP1178047B1 (fr) Dérivées des composés diazacycloactanes et leur usage thérapeutique
AU597412B2 (en) Substituted hexahydroarylquinolizines
HUT58318A (en) Process for producing pirimidinyl derivatives
US4831035A (en) Substituted hexahydroarylquinolizines
KR100222238B1 (ko) 스피로 교상 및 비교상 헤테로고리 화합물
NO304522B1 (no) AnologifremgangsmÕte for fremstilling av terapeutisk aktive heterocykliske forbindelser
TW201312B (en) Spiro bridged and unbridged heterocyclic compounds
US4916223A (en) Substituted hexahydroarylquinolizines
US6875774B2 (en) Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands
NZ229794A (en) Tetrahydro-isoxazolo(4,5-d)azepine derivatives and pharmaceutical compositions
MX2007000948A (es) (1s, 5s)-3-(5, 6-dicloro-3 -piridinil)-3, 6-diazabiciclo [3.2.0] heptano.
CA2146000A1 (fr) Derives de substitution en 3,3 d'indolin-2-ones tri- et tetracycliques, utiles pour le traitement de troubles cognitifs

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees